{"schema_version":"secwatch.filing_event.v1","accession":"0000950142-23-000510","form_type":"8-K","ticker":"NRXP","cik":"0001719406","company_name":"NRX Pharmaceuticals, Inc.","filed_at":"2023-02-23T23:59:59+00:00","discovered_at":"2026-05-14T18:03:46.298527+00:00","generated_at":"2026-06-19T03:00:32.927380+00:00","sec_items":["5.02"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"confidence":"high","headline":"NRx Pharmaceuticals CCO Robert Besthof resigns; hires Windhaul Partners for commercial strategy","bullets":["Robert Besthof, Head of Operations and CCO, resigned effective Feb 16, 2023; will stay for transition.","Company in discussions with Besthof for part-time advisor role.","Hired Windhaul Partners and President Frank Sanders (ex-Sage Therapeutics) to advise on expanded commercial plan.","FDA recommended expanded 'Chronic/Intermittent' indication for lead compound NRX-101, prompting expanded commercial strategy."],"urls":{"canonical":"https://secwatch.observer/filing/0000950142-23-000510","json":"https://secwatch.observer/filing/0000950142-23-000510.json","markdown":"https://secwatch.observer/filing/0000950142-23-000510.md","text":"https://secwatch.observer/filing/0000950142-23-000510.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1719406/000095014223000510/0000950142-23-000510-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1719406/000095014223000510/eh230333134_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-19T03:00:32.927380+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"48b49a0666","claim":"Robert Besthof resigned as Head of Operations and Chief Commercial Officer at NRX Pharmaceuticals, Inc..","evidence_excerpt":"On February 16, 2023, Mr. Robert Besthof, NRx Pharmaceuticals, Inc.’s (the “Company”) Head of Operations and Chief Commercial Officer, notified the Company of his resignation.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1719406/000095014223000510/0000950142-23-000510-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"resigned"},{"label":"Role","value":"Head of Operations and Chief Commercial Officer"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}